Guggenheim Capital’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Guggenheim Capital’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-18,643	Closed	-$91K	–	2213
2019 Q3	$91K	Buy	+18,643	New	+$104K	﹤0.01%	2069
2018 Q4	–	Sell	-14,787	Closed	-$287K	–	2448
2018 Q3	$287K	Buy	14,787 +3,257	+28%	+$69.3K	﹤0.01%	2228
2018 Q2	$295K	Sell	11,530 -61,870	-84%	-$1.44M	﹤0.01%	2196
2018 Q1	$1.48M	Sell	73,400 -13,010	-15%	-$304K	﹤0.01%	1846
2017 Q4	$1.74M	Sell	86,410 -87,099	-50%	-$1.71M	﹤0.01%	1772
2017 Q3	$3.59M	Buy	173,509 +29,390	+20%	+$497K	0.01%	1264
2017 Q2	$2.13M	Sell	144,119 -50,794	-26%	-$847K	0.01%	1580
2017 Q1	$3.11M	Sell	194,913 -39,282	-17%	-$567K	0.01%	1325
2016 Q4	$2.95M	Buy	+234,195	New	+$4.36M	0.01%	1381
2015 Q3	–	Sell	-4,789	Closed	-$214K	–	3056
2015 Q2	$214K	Buy	+4,789	New	+$180K	﹤0.01%	2807

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Guggenheim Capital's DPLO Position: Q4 2019 in Review

Guggenheim Capital sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 18,643 shares — an estimated $91K sold.

Guggenheim Capital first reported a position in DPLO in Q2 2015 and held it in 10 quarters. The position peaked at $3.59M in Q3 2017. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

Guggenheim Capital reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
Guggenheim Capital sold 18,643 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $91K.
Guggenheim Capital first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 10 quarters.
Guggenheim Capital's DIPLOMAT PHARMACY, INC. position peaked at $3.59M in Q3 2017.
138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Guggenheim Capital's 13F filing for Q4 2019, filed 14 Feb 2020.